Premarket Mover: AbCellera Biologics Inc (ABCL) Up 2.85%

AbCellera Biologics Inc (ABCL) has risen Thursday morning, with the stock adding 2.85% in pre-market trading to 5.05. ABCL's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Biotechnology industry, which ranks 101 out of 146 industries, the stock ranks higher than 25% of stocks. AbCellera Biologics Inc has fallen 10.07% over the past month, closing at $5.28 on February 15. During this period of time, the stock fell as low as $4.77 and as high as $5.45. ABCL has an average analyst recommendation of Strong Buy. The company has an average price target of $15.56.

ABCL has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on ABCL!

See Full ABCL Report

AbCellera Biologics Inc has a Long-Term Technical rank of 32. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 68% of the market scoring higher. In the Biotechnology industry which is number 72 by this metric, ABCL ranks better than 72% of stocks.

Important Dates for Investors in ABCL:

-AbCellera Biologics Inc is set to release earnings on 2024-05-02. Over the last 12 months, the company has reported EPS of $-0.44. -We do not have a set dividend date for AbCellera Biologics Inc at this time. Click Here To Get The Full Report on AbCellera Biologics Inc (ABCL)